Xeris Biopharma Reports Third Quarter 2023 Financial Results
Go back to Xeris Biopharma Reports Third Quarter 2023 Financial Results| (NASDAQ: XERS) | Delayed: 8.61 -0.17 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.78 | 52 Week High | $ | |||
| Open | $8.91 | 52 Week Low | $ | |||
| Day High | $8.99 | P/E | N/A | |||
| Day Low | $8.56 | EPS | $ | |||
| Volume | 1,248,285 | |||||

